We decided to study the response of TXNIP-ROS-TRX axis in vitro as a mimicker of the in vivo situation involving a patient who either experiences GC-induced hyperglycemia or uses DEX in a condition of existing frank diabetes. The gene discussed is TXNIP; the disease is diabetes mellitus.